AriBio (AriBio)
Seongnam-si, South Korea
AriBio is a clinical-stage biotech company located in Seongnam, South Korea focused on developing novel therapeutics for neurodegenerative diseases. The US office is located in San Diego managing global clinical operations and regulatory affairs. The lead asset, AR1001, is entering a global phase 3 program this year.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2010
- Website
- aribio.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of AriBio (AriBio)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now